Abstract:Resistance to amikacin and other major aminoglycosides is commonly due to enzymatic acetylation by aminoglycoside 6′-N-acetyltransferase type I enzyme, of which type Ib [AAC(6′)-Ib] is the most widespread among Gram-negative pathogens. Finding enzymatic inhibitors could be an effective way to overcome resistance and extend the useful life of amikacin. Small molecules possess multiple properties that make them attractive compounds to be developed as drugs. Mixture-based combinatorial libraries and positional scanning strategy led to the identification of a chemical scaffold, pyrrolidine pentamine, that, when substituted with the appropriate functionalities at five locations (R1 - R5), inhibits AAC(6′)-Ib-mediated inactivation of amikacin. Structure-activity relationship (SAR) studies showed that while truncations to the molecule result in loss of inhibitory activity, modifications of functionalities and stereochemistry have different effects on the inhibitory properties. In this study, we show that alterations at position R1 of the two most active compounds, 2700.001 and 2700.003, reduced inhibition levels, demonstrating the essential nature not only of the presence of an S-phenyl moiety at this location but also the distance to the scaffold. On the other hand, modifications on the R3, R4, and R5 positions have varied effects, demonstrating the potential for optimization. A correlation analysis between molecular docking values (ΔG) and the dose required for two-fold potentiation of compounds described in this and the previous studies showed a significant correlation between ΔG values and inhibitory activity.

What problem does this paper attempt to address?

### Problems the paper attempts to solve This paper aims to solve the problem of amikacin resistance caused by the aminoglycoside antibiotic 6′-N - acetyltransferase type Ib (AAC(6′)-Ib). Specifically, the research team hopes to overcome this resistance by finding effective inhibitors, thereby prolonging the clinical lifespan of amikacin. ### Background and motivation 1. **Multidrug - resistance problem**: - Multidrug - resistance is one of the major challenges currently facing human health, resulting in more and more people dying from infections. - The speed of antibiotic research and development is far behind the speed of resistance development, and new strategies are urgently needed to deal with this problem. 2. **Importance of amikacin**: - Amikacin is an important aminoglycoside antibiotic widely used in the treatment of life - threatening infections. - However, due to the inactivation of amikacin by the acetylation of bacteria through the AAC(6′)-Ib enzyme, its resistance problem is becoming increasingly serious. 3. **Limitations of existing research**: - Currently, although some studies have attempted to design new aminoglycoside antibiotics through semi - synthetic methods, these efforts have not yet been able to completely solve the resistance problem. - In particular, there are relatively few studies on inhibitors of the AAC(6′)-Ib enzyme, and there are no clinically available inhibitors at present. ### Research objectives 1. **Identify effective inhibitors**: - Through combinatorial library and position - scanning strategies, identify small - molecule compounds that can effectively inhibit the activity of the AAC(6′)-Ib enzyme. 2. **Optimize inhibitor structure**: - Through structure - activity relationship (SAR) studies, further optimize the discovered inhibitors to improve their inhibitory effect and selectivity. 3. **Verify the effectiveness of inhibitors**: - Verify the inhibitory effects of these inhibitors at different concentrations through in vitro experiments, and evaluate their synergistic effects when used in combination with amikacin. ### Main findings 1. **Preliminary screening of inhibitors**: - Through combinatorial library and position - scanning strategies, the research team discovered a compound 2637.001 based on a pyrrolidine pentamine skeleton, which has a good inhibitory effect. 2. **SAR studies**: - Further SAR studies have shown that the S - phenyl group at the R1 position is crucial for the inhibitory effect, and any modification will significantly reduce the inhibitory activity. - Modification at the R4 position also has an important impact on the inhibitory effect. In particular, when the phenyl group is moved away from the skeleton, the inhibitory activity decreases significantly. 3. **Molecular docking analysis**: - Molecular docking studies have shown that there is a significant correlation between the binding energy (ΔG) of the compound and the inhibitory activity, which provides a theoretical basis for further optimizing the inhibitor. ### Conclusion This study has successfully identified and optimized a series of effective AAC(6′)-Ib enzyme inhibitors through systematic SAR studies and molecular docking analysis. These inhibitors are expected to be used in combination with amikacin to overcome the resistance problem caused by the AAC(6′)-Ib enzyme and prolong the clinical lifespan of amikacin.

Structure-activity relationship of pyrrolidine pentamine derivatives as inhibitors of the aminoglycoside 6'- -acetyltransferase type Ib

Structure–Activity Relationship of Pyrrolidine Pentamine Derivatives as Inhibitors of the Aminoglycoside 6′-N-Acetyltransferase Type Ib

Discovery of 2-Aminothiazolyl Berberine Derivatives As Effectively Antibacterial Agents Toward Clinically Drug-Resistant Gram-negative Acinetobacter Baumanii.

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Designing potential lead compounds targeting aminoglycoside N (6′)-acetyltransferase in Serratia marcescens : A drug discovery strategy

Design, Synthesis and Activity Evaluation Against Drug‐Resistant Bacteria of 6'‐Amidine Modified Aminoglycoside Derivatives

Structure–activity Relationship Studies of [1,2,5]Oxadiazolo[3,4-B]pyrazine-containing Polymyxin-Selective Resistance-Modifying Agents

Cyclic Peptide MV6, an Aminoglycoside Efficacy Enhancer Against Acinetobacter baumannii

Amikacin potentiator activity of zinc complexed to a pyrithione derivative with enhanced solubility

Effects of Altering Aminoglycoside Structures on Bacterial Resistance Enzyme Activities

Chemical and structural insights into the regioversatility of the aminoglycoside acetyltransferase Eis.

Development of Aminoglycoside Antibiotics Effective Against Resistant Bacterial Strains

Synthesis, Antimicrobial Evaluation and Docking Study of Novel 3,5-Disubstituted-2-Isoxazoline and 1,3,5-Trisubstituted-2-Pyrazoline Derivatives

Development of a chemical scaffold for inhibiting nonribosomal peptide synthetases in live bacterial cells

Antibiotic resistance and inhibition mechanism of novel aminoglycoside phosphotransferase APH(5) from B. subtilis subsp. subtilis strain RK

Identification of a 2‐aminobenzimidazole scaffold that potentiates gram‐positive selective antibiotics against gram‐negative bacteria

Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics

Structural analysis of neomycin B and kanamycin A binding Aminoglycosides Modifying Enzymes (AME) and bacterial ribosomal RNA

Dynamics and quantitative contribution of the aminoglycoside 6′-N-acetyltransferase type Ib to amikacin resistance

Structural and Biochemical Characterization of Aminoglycoside Nucleotidyltransferase(6)-Ib From Campylobacter fetus subsp. fetus

5 '-O-[(N-Acyl)Sulfamoyl]Adenosines As Antitubercular Agents That Inhibit Mbta: An Adenylation Enzyme Required For Siderophore Biosynthesis Of The Mycobactins